L&T Technology Services Develops AI-Powered Diagnostic Platform
Filing Summary
L&T Technology Services Limited (LTTS) has announced the development of an AI-powered digital twin platform for respiratory diagnostics. This platform, created in collaboration with NVIDIA, integrates with CT imaging and utilizes deep learning models to create a 3D digital twin of lung anatomy. The solution is designed to enhance diagnostic precision and improve accessibility for healthcare providers. The platform will be unveiled at the Radiological Society of North America (RSNA) 2025. LTTS leverages its expertise in MedTech and NVIDIA’s AI infrastructure to deliver scalable solutions for the healthcare industry.
L&T Technology Services Limited (LTTS) has announced the creation of an AI-powered digital twin platform for respiratory diagnostics and lung navigation. This development is in collaboration with NVIDIA and aims to enhance diagnostic precision and accessibility for healthcare providers. The platform integrates with CT imaging and leverages deep learning models to create a 3D digital twin of lung anatomy. It will be unveiled at the Radiological Society of North America (RSNA) 2025.
The filing does not disclose specific financial terms or payment structures related to the development of this platform. The focus is on the technological collaboration between LTTS and NVIDIA, combining LTTS’ expertise in AI-driven diagnostics and NVIDIA’s AI infrastructure. The platform is designed to deliver scalable, low-latency solutions for the healthcare industry.
The scope of the project includes the integration of the platform with CT imaging and the use of deep learning models to create a 3D digital twin of lung anatomy. This includes visualization of airways, blood vessels, lung lobes, and lesions. The platform is powered by NVIDIA MONAI for medical image segmentation and NVIDIA TensorRT for optimized AI inference. It provides interactive visualization, precise path planning, and navigation support for bronchoscopy, assisting clinicians in navigating complex procedures efficiently.
The platform is intended to transform surgical planning and advance care for conditions such as lung cancer, COPD, and infectious diseases. LTTS’ deep domain engineering expertise in medical imaging and proprietary navigation systems ensures the platform delivers clinically meaningful simulations that mirror real-world anatomy.
The timeline for the unveiling of the platform is set for the Radiological Society of North America (RSNA) 2025. The collaboration involves LTTS and NVIDIA, with LTTS focusing on platform engineering and AI-driven diagnostics, while NVIDIA provides the AI infrastructure and modeling capabilities.
NVIDIA is a leader in AI computing and provides infrastructure that supports the development of AI-enabled medical technology. The collaboration with LTTS demonstrates NVIDIA’s commitment to empowering the healthcare industry with accelerated computing and AI innovation.
L&T Technology Services Limited (LTTS) is a global leader in AI, Digital & ER&D Consulting Services. As a subsidiary of Larsen & Toubro, LTTS offers design, development, testing, and sustenance services across various sectors. The company serves 69 Fortune 500 companies and 57 top ER&D companies, focusing on mobility, sustainability, and technology segments.